Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001371921 | SCV001568505 | likely benign | Seizures, benign familial infantile, 3; Developmental and epileptic encephalopathy, 11 | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003264022 | SCV003948735 | uncertain significance | Inborn genetic diseases | 2023-05-22 | criteria provided, single submitter | clinical testing | The c.3556A>G (p.I1186V) alteration is located in exon 19 (coding exon 18) of the SCN2A gene. This alteration results from a A to G substitution at nucleotide position 3556, causing the isoleucine (I) at amino acid position 1186 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |